A loss of hormone receptor expression is one of the primary drivers of resistance to antihormonal therapy in breast cancer patients.[3d] An analysis of available TCGA data indicated that TRIM4 expression was closely related to luminal subtypes of breast cancer but not to TNBC (Figure3A,B). Here, TRIM4 is linked to breast carcinoma.